Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) |
Preferred Stock [Member]
Series A-5 Preferred Stock [Member]
|
Preferred Stock [Member]
Series AA Convertible Preferred Stock [Member]
|
Preferred Stock [Member]
Series AA-2 Convertible Preferred Stock [Member]
|
Preferred Stock [Member]
Series AA-3 Convertible Preferred Stock [Member]
|
Preferred Stock [Member]
Series AA-4 Convertible Preferred Stock [Member]
|
Preferred Stock [Member]
Series AA-5 Convertible Preferred Stock [Member]
|
Preferred Stock [Member]
Series A Preferred Stock [Member]
|
Preferred Stock [Member]
Series A A Preferred Stock [Member]
|
Preferred Stock [Member] |
Common Stock [Member]
Series A Preferred Stock [Member]
|
Common Stock [Member]
Series A A Preferred Stock [Member]
|
Common Stock [Member]
Pre-Funded Warrant [Member]
|
Common Stock [Member]
Melon Acquisition [Member]
|
Common Stock [Member]
Superbiz Acquisition [Member]
|
Common Stock [Member]
Bannerfy Acquisition [Member]
|
Common Stock [Member] |
Additional Paid-in Capital [Member]
Series A-5 Preferred Stock [Member]
|
Additional Paid-in Capital [Member]
Series AA Convertible Preferred Stock [Member]
|
Additional Paid-in Capital [Member]
Series AA-2 Convertible Preferred Stock [Member]
|
Additional Paid-in Capital [Member]
Series AA-3 Convertible Preferred Stock [Member]
|
Additional Paid-in Capital [Member]
Series AA-4 Convertible Preferred Stock [Member]
|
Additional Paid-in Capital [Member]
Series AA-5 Convertible Preferred Stock [Member]
|
Additional Paid-in Capital [Member]
Melon Acquisition [Member]
|
Additional Paid-in Capital [Member]
Superbiz Acquisition [Member]
|
Additional Paid-in Capital [Member]
Bannerfy Acquisition [Member]
|
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Series A-5 Preferred Stock [Member] |
Series AA Convertible Preferred Stock [Member] |
Series AA-2 Convertible Preferred Stock [Member] |
Series AA-3 Convertible Preferred Stock [Member] |
Series AA-4 Convertible Preferred Stock [Member] |
Series AA-5 Convertible Preferred Stock [Member] |
Series A Preferred Stock [Member] |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total stockholders’ equity | $ 0 | $ 46,000 | $ 215,943,000 | $ (125,292,000) | |||||||||||||||||||||||||||||||
Balance (in shares) at Dec. 31, 2021 | 0 | ||||||||||||||||||||||||||||||||||
Issuance of Series A preferred stock at $1,000 per share (in shares) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||
Conversion of Series A preferred stock (in shares) | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||
Balance (in shares) at Sep. 30, 2022 | 0 | ||||||||||||||||||||||||||||||||||
Balance at Dec. 31, 2021 | $ 0 | $ 46,000 | 215,943,000 | (125,292,000) | |||||||||||||||||||||||||||||||
Issuance of Series A preferred stock at $1,000 per share | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | 0 | ||||||||||||||||||||
Conversion of Series A preferred stock | $ 0 | $ 0 | |||||||||||||||||||||||||||||||||
Balance (in shares) at Dec. 31, 2021 | 1,840,459 | ||||||||||||||||||||||||||||||||||
Common stock issued for Acquisition (in shares) | 0 | 0 | 2,683 | ||||||||||||||||||||||||||||||||
Stock-based compensation (in shares) | 16,354 | ||||||||||||||||||||||||||||||||||
Other (in shares) (in shares) | 19,053 | ||||||||||||||||||||||||||||||||||
Balance (in shares) at Sep. 30, 2022 | 1,878,549 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | $ 0 | 3,284,000 | |||||||||||||||||||||||||||||||||
Common stock issued for Acquisition | $ 0 | $ 0 | $ 0 | $ 0 | $ 220,000 | ||||||||||||||||||||||||||||||
us-gaap_StockholdersEquityOther | 1,000 | ||||||||||||||||||||||||||||||||||
Exercise of prefunded common stock warrants at $2.60 per share, net of issuance costs | 0 | ||||||||||||||||||||||||||||||||||
Common stock purchase warrants issued to placement agent | 0 | ||||||||||||||||||||||||||||||||||
Other | 320,000 | ||||||||||||||||||||||||||||||||||
Net Loss | (69,238,000) | $ (69,238,000) | |||||||||||||||||||||||||||||||||
Balance at Sep. 30, 2022 | 0 | 47,000 | 219,767,000 | (194,530,000) | $ 25,284,000 | ||||||||||||||||||||||||||||||
Total stockholders’ equity | $ 0 | 46,000 | 218,050,000 | (141,928,000) | |||||||||||||||||||||||||||||||
Balance (in shares) at Jun. 30, 2022 | 0 | ||||||||||||||||||||||||||||||||||
Issuance of Series A preferred stock at $1,000 per share (in shares) | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||
Conversion of Series A preferred stock (in shares) | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
Balance (in shares) at Sep. 30, 2022 | 0 | ||||||||||||||||||||||||||||||||||
Balance at Jun. 30, 2022 | $ 0 | 46,000 | 218,050,000 | (141,928,000) | |||||||||||||||||||||||||||||||
Issuance of Series A preferred stock at $1,000 per share | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||
Conversion of Series A preferred stock | $ 0 | $ 0 | |||||||||||||||||||||||||||||||||
Balance (in shares) at Jun. 30, 2022 | 1,852,189 | ||||||||||||||||||||||||||||||||||
Common stock issued for Acquisition (in shares) | 0 | 0 | 2,683 | ||||||||||||||||||||||||||||||||
Stock-based compensation (in shares) | 7,495 | ||||||||||||||||||||||||||||||||||
Other (in shares) (in shares) | 16,182 | ||||||||||||||||||||||||||||||||||
Balance (in shares) at Sep. 30, 2022 | 1,878,549 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | $ 0 | 1,185,000 | |||||||||||||||||||||||||||||||||
Common stock issued for Acquisition | $ 0 | $ 0 | 0 | 0 | 220,000 | ||||||||||||||||||||||||||||||
us-gaap_StockholdersEquityOther | 1,000 | ||||||||||||||||||||||||||||||||||
Exercise of prefunded common stock warrants at $2.60 per share, net of issuance costs | 0 | ||||||||||||||||||||||||||||||||||
Common stock purchase warrants issued to placement agent | 0 | ||||||||||||||||||||||||||||||||||
Other | 312,000 | ||||||||||||||||||||||||||||||||||
Net Loss | (52,602,000) | $ (52,602,000) | |||||||||||||||||||||||||||||||||
Balance at Sep. 30, 2022 | 0 | 47,000 | 219,767,000 | (194,530,000) | 25,284,000 | ||||||||||||||||||||||||||||||
Total stockholders’ equity | 0 | 47,000 | 219,767,000 | (194,530,000) | 25,284,000 | ||||||||||||||||||||||||||||||
Total stockholders’ equity | $ 0 | $ 47,000 | 229,900,000 | (210,743,000) | $ 19,204,000 | ||||||||||||||||||||||||||||||
Balance (in shares) at Dec. 31, 2022 | 10,323 | ||||||||||||||||||||||||||||||||||
Issuance of Series A preferred stock at $1,000 per share (in shares) | 2,299 | 7,680 | 1,500 | 1,025 | 1,026 | 550 | 811,269 | 7,680 | 1,500 | 1,025 | 1,026 | 550 | 67,500 | ||||||||||||||||||||||
Conversion of Series A preferred stock (in shares) | (5,729) | (2,797) | 766,128 | 187,000 | 180,000 | 0 | |||||||||||||||||||||||||||||
Balance (in shares) at Sep. 30, 2023 | 15,877 | ||||||||||||||||||||||||||||||||||
Balance at Dec. 31, 2022 | $ 0 | $ 47,000 | 229,900,000 | (210,743,000) | $ 19,204,000 | ||||||||||||||||||||||||||||||
Issuance of Series A preferred stock at $1,000 per share | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | 1,000 | 16,000 | 1,919,000 | 6,518,000 | 1,370,000 | 892,000 | 893,000 | 479,000 | 1,710,000 | ||||||||||||||||||||
Conversion of Series A preferred stock | $ 0 | $ 15,000 | |||||||||||||||||||||||||||||||||
Balance (in shares) at Dec. 31, 2022 | 1,880,299 | 1,880,298 | |||||||||||||||||||||||||||||||||
Common stock issued for Acquisition (in shares) | 77,833 | 49,398 | 8,984 | ||||||||||||||||||||||||||||||||
Stock-based compensation (in shares) | 9,458 | ||||||||||||||||||||||||||||||||||
Other (in shares) (in shares) | 0 | ||||||||||||||||||||||||||||||||||
Balance (in shares) at Sep. 30, 2023 | 4,170,085 | 4,170,085 | |||||||||||||||||||||||||||||||||
Stock-based compensation | $ 0 | 1,986,000 | |||||||||||||||||||||||||||||||||
Common stock issued for Acquisition | $ 1,000 | $ 1,000 | 721,000 | 547,000 | 70,000 | ||||||||||||||||||||||||||||||
us-gaap_StockholdersEquityOther | 0 | ||||||||||||||||||||||||||||||||||
Exercise of prefunded common stock warrants at $2.60 per share, net of issuance costs | 158,000 | ||||||||||||||||||||||||||||||||||
Common stock purchase warrants issued to placement agent | (2,804,000) | ||||||||||||||||||||||||||||||||||
Other | (26,000) | ||||||||||||||||||||||||||||||||||
Net Loss | (17,056,000) | $ (17,056,000) | |||||||||||||||||||||||||||||||||
Balance at Sep. 30, 2023 | 0 | 81,000 | 244,333,000 | (227,799,000) | $ 16,615,000 | ||||||||||||||||||||||||||||||
Total stockholders’ equity | $ 0 | $ 57,000 | 241,833,000 | (224,815,000) | |||||||||||||||||||||||||||||||
Balance (in shares) at Jun. 30, 2023 | 19,892 | ||||||||||||||||||||||||||||||||||
Issuance of Series A preferred stock at $1,000 per share (in shares) | 0 | 0 | 0 | 0 | 0 | 0 | 811,269 | 67,500 | |||||||||||||||||||||||||||
Conversion of Series A preferred stock (in shares) | (1,218) | (2,797) | 99,463 | 766,128 | 0 | ||||||||||||||||||||||||||||||
Balance (in shares) at Sep. 30, 2023 | 15,877 | ||||||||||||||||||||||||||||||||||
Balance at Jun. 30, 2023 | $ 0 | $ 57,000 | 241,833,000 | (224,815,000) | |||||||||||||||||||||||||||||||
Issuance of Series A preferred stock at $1,000 per share | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 1,000 | 16,000 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | 1,710,000 | ||||||||||||||||||||
Conversion of Series A preferred stock | $ 0 | $ 7,000 | |||||||||||||||||||||||||||||||||
Balance (in shares) at Jun. 30, 2023 | 2,416,741 | ||||||||||||||||||||||||||||||||||
Common stock issued for Acquisition (in shares) | 0 | 0 | 8,984 | ||||||||||||||||||||||||||||||||
Stock-based compensation (in shares) | 0 | ||||||||||||||||||||||||||||||||||
Other (in shares) (in shares) | 0 | ||||||||||||||||||||||||||||||||||
Balance (in shares) at Sep. 30, 2023 | 4,170,085 | 4,170,085 | |||||||||||||||||||||||||||||||||
Stock-based compensation | $ 0 | 580,000 | |||||||||||||||||||||||||||||||||
Common stock issued for Acquisition | $ 0 | $ 0 | $ 0 | $ 0 | $ 70,000 | ||||||||||||||||||||||||||||||
us-gaap_StockholdersEquityOther | 0 | ||||||||||||||||||||||||||||||||||
Exercise of prefunded common stock warrants at $2.60 per share, net of issuance costs | 158,000 | ||||||||||||||||||||||||||||||||||
Common stock purchase warrants issued to placement agent | 0 | ||||||||||||||||||||||||||||||||||
Other | (18,000) | ||||||||||||||||||||||||||||||||||
Net Loss | (2,984,000) | $ (2,984,000) | |||||||||||||||||||||||||||||||||
Balance at Sep. 30, 2023 | 0 | 81,000 | 244,333,000 | (227,799,000) | 16,615,000 | ||||||||||||||||||||||||||||||
Total stockholders’ equity | $ 0 | $ 81,000 | $ 244,333,000 | $ (227,799,000) | $ 16,615,000 |